PRFX
Price
$1.39
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
2.8M
45 days until earnings call
ZTS
Price
$143.50
Change
+$2.37 (+1.68%)
Updated
Sep 26 closing price
Capitalization
63.6B
36 days until earnings call
Interact to see
Advertisement

PRFX vs ZTS

Header iconPRFX vs ZTS Comparison
Open Charts PRFX vs ZTSBanner chart's image
PainReform
Price$1.39
Change-$0.00 (-0.00%)
Volume$129.7K
Capitalization2.8M
ZOETIS
Price$143.50
Change+$2.37 (+1.68%)
Volume$2.58M
Capitalization63.6B
PRFX vs ZTS Comparison Chart in %
Loading...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRFX vs. ZTS commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRFX is a StrongBuy and ZTS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (PRFX: $1.39 vs. ZTS: $143.50)
Brand notoriety: PRFX: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRFX: 3% vs. ZTS: 85%
Market capitalization -- PRFX: $2.8M vs. ZTS: $63.6B
PRFX [@Pharmaceuticals: Generic] is valued at $2.8M. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $63.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRFX’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • PRFX’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRFX’s TA Score shows that 2 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • PRFX’s TA Score: 2 bullish, 6 bearish.
  • ZTS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than PRFX.

Price Growth

PRFX (@Pharmaceuticals: Generic) experienced а -6.08% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

PRFX is expected to report earnings on Nov 13, 2025.

ZTS is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($63.6B) has a higher market cap than PRFX($2.8M). ZTS YTD gains are higher at: -11.065 vs. PRFX (-58.569). PRFX has less debt than ZTS: PRFX (59K) vs ZTS (6.79B).
PRFXZTSPRFX / ZTS
Capitalization2.8M63.6B0%
EBITDAN/A4.02B-
Gain YTD-58.569-11.065529%
P/E RatioN/A24.70-
RevenueN/A9.39B-
Total CashN/A1.44B-
Total Debt59K6.79B0%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRFXZTS
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
60%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
66%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
59%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 25 days ago
57%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
57%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOH191.982.68
+1.42%
Molina Healthcare
ZNB1.650.02
+1.23%
Zeta Network Group
CTKB3.400.01
+0.29%
Cytek Biosciences
DV11.890.03
+0.25%
DoubleVerify Holdings
TDTH0.92-0.04
-4.17%
Trident Digital Tech Holdings Ltd

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and BHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and BHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
N/A
BHC - PRFX
26%
Poorly correlated
+0.31%
AMRX - PRFX
24%
Poorly correlated
+1.56%
EVOK - PRFX
24%
Poorly correlated
-2.20%
ZTS - PRFX
22%
Poorly correlated
+1.68%
PBH - PRFX
21%
Poorly correlated
+0.40%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+1.68%
VTRS - ZTS
48%
Loosely correlated
+0.32%
ELAN - ZTS
47%
Loosely correlated
+3.65%
PAHC - ZTS
41%
Loosely correlated
+2.02%
AMRX - ZTS
38%
Loosely correlated
+1.56%
HLN - ZTS
38%
Loosely correlated
+1.15%
More